Sören Kuitunen-Paul
Biographic Data
| ID | 7233302 |
|---|---|
| NAME | Sören Kuitunen-Paul |
| GIVEN NAMES | Sören |
| FAMILY NAME | Kuitunen-Paul |
| SIGNATURE | KUITUNEN-PAUL S |
| AFFILIATIONS | Technische Universität Dresden |
| ORCID | 0000-0001-8224-6490 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 9 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Evaluation of the multimodal Delta therapy for adolescents with substance use disorders
DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)
Study protocol
This study will create a setting-specific manual for vulnerable adolescents suffering from SUDs, and, in many cases, from co-occurring mental disorders. If shown to be effective, DELTA-JU can be disseminated within other institutions of youth welfare
Motives for the use of serotonergic psychedelics
Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…
Delta – Dresdner Multimodale Therapie für Jugendliche mit chronischem Suchtmittelkonsum
Traumatic Events and Substance Use Disorders in Adolescents
Adolescent patients with SUD reported 3-times higher rates of TEs, and a 5-time higher prevalence of PTSD following TEs, than the general adolescent population. Adolescent SUD patients with PTSD reported more severe substance use problems than patients without PTSD-regardless of previous TEs. Longitudinal studies are needed in order to investigate the temporal relationship between TEs, PTSD and SUD
Assignment of Alcoholic Beverages in the Munich Composite International Diagnostic Interview (M-CIDI)
A Psychometric Evaluation of User-Generated Cannabis Use Motives in German University Students
Alcohol Use Disorders Identification Test (Audit) and mortality risk
No prominent works on this page.
Alcohol Use Disorders Identification Test (Audit) and mortality risk
Assignment of Alcoholic Beverages in the Munich Composite International Diagnostic Interview (M-CIDI)
A Psychometric Evaluation of User-Generated Cannabis Use Motives in German University Students
Traumatic Events and Substance Use Disorders in Adolescents
Adolescent patients with SUD reported 3-times higher rates of TEs, and a 5-time higher prevalence of PTSD following TEs, than the general adolescent population. Adolescent SUD patients with PTSD reported more severe substance use problems than patients without PTSD-regardless of previous TEs. Longitudinal studies are needed in order to investigate the temporal relationship between TEs, PTSD and SUD
Delta – Dresdner Multimodale Therapie für Jugendliche mit chronischem Suchtmittelkonsum
Motives for the use of serotonergic psychedelics
Attenuated Psychotic Symptoms in Adolescents With Chronic Cannabis and MDMA Use
Our results indicate that MDMA use additional to cannabis use is associated with APS among adolescent SUD patients. Contrary to our expectations, we did not see an association of cannabis use and APS. We speculate that cannabis increases the risk for psychosis after a longer period of use and in combination with other risk factors, such as trauma history. Clinicians should screen for APS among SUD patients using MDMA and cannabis in order to adap…
Study protocol
This study will create a setting-specific manual for vulnerable adolescents suffering from SUDs, and, in many cases, from co-occurring mental disorders. If shown to be effective, DELTA-JU can be disseminated within other institutions of youth welfare
Evaluation of the multimodal Delta therapy for adolescents with substance use disorders
DELTA showed small effects on SUD-related and depression-related variables. However, the interpretation is limited by the small sample size. Nonetheless, the DELTA intervention is viable in SUD outpatient treatment and will be further evaluated. Clinical trial registration : The study was registered at clinicaltrials.gov under NCT03444974. Registered February, 26th 2018 (https://clinicaltrials.gov/ct2/show/NCT03444974)
Medicine (7 works) · Psychiatry (6 works) · Psychology (6 works) · Clinical Psychology (5 works) · Clinical Psychology (5 works) · Child and Adolescent Psychosocial and Emotional Development (3 works) · Substance abuse (3 works) · Cannabis (2 works) · Cannabis and Cannabinoid Research (2 works) · German (2 works)